Jim Edwards
bnet.com
September 10, 2009
The journal Archives of General Psychiatry will “look into” whether an author who recommended antidepressants for preschoolers failed to disclose her financial ties to Johnson & Johnson, AstraZeneca and, companies which make such drugs, according to Philip Dawdy of Furious Seasons.
Dr. Joan Luby, a professor of child psychiatry at the Washington University School of Medicine in St. Louis, has authored several papers asserting that children as young as three years old can suffer from depression and bipolar disorder, and that treatment with antidepressants and antipsychotics may be appropriate. In a recent paper of the AGP, she wrote:
Preschool depression, similar to childhood depression, is not a developmentally transient syndrome but rather shows chronicity and/or recurrence.
She did not disclose any ties to industry. However, Luby has past ties to J&J’s Janssen unit, AZ and Shire (makers of Risperdal, Seroquel and Adderall XR, respectively).
Read entire article: http://industry.bnet.com/pharma/10004189/agp-to-probe-undisclosed-industry-ties-of-doc-who-recommends-antidepressants-for-3-year-olds/
News Feed
Related Posts
Tags: Adderall XR, AGP, antidepressants, antipsychotics, AstraZeneca, Dr. Joan Luby, Johnson & Johnson, psychiatrist, psychiatry, Risperdal, Seroquel, Shire
You can leave a response, or trackback from your own site.
Donate
I enjoy this site, it is worth me coming back